These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9143014)

  • 21. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length.
    Becher MW; Kotzuk JA; Sharp AH; Davies SW; Bates GP; Price DL; Ross CA
    Neurobiol Dis; 1998 Apr; 4(6):387-97. PubMed ID: 9666478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families.
    Nørremølle A; Riess O; Epplen JT; Fenger K; Hasholt L; Sørensen SA
    Hum Mol Genet; 1993 Sep; 2(9):1475-6. PubMed ID: 8242074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
    Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
    Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neurology and natural history of patients with indeterminate CAG repeat length mutations of the Huntington disease gene.
    Panegyres PK; Goh JG
    J Neurol Sci; 2011 Feb; 301(1-2):14-20. PubMed ID: 21147489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early atrophy of pallidum and accumbens nucleus in Huntington's disease.
    van den Bogaard SJ; Dumas EM; Acharya TP; Johnson H; Langbehn DR; Scahill RI; Tabrizi SJ; van Buchem MA; van der Grond J; Roos RA;
    J Neurol; 2011 Mar; 258(3):412-20. PubMed ID: 20936300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease.
    Squitieri F; Cannella M; Simonelli M; Sassone J; Martino T; Venditti E; Ciammola A; Colonnese C; Frati L; Ciarmiello A
    CNS Neurosci Ther; 2009; 15(1):1-11. PubMed ID: 19228174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transglutaminase activity is related to CAG repeat length in patients with Huntington's disease.
    Cariello L; de Cristofaro T; Zanetti L; Cuomo T; Di Maio L; Campanella G; Rinaldi S; Zanetti P; Di Lauro R; Varrone S
    Hum Genet; 1996 Dec; 98(6):633-5. PubMed ID: 8931689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Huntington's Disease: Relationship Between Phenotype and Genotype.
    Sun YM; Zhang YB; Wu ZY
    Mol Neurobiol; 2017 Jan; 54(1):342-348. PubMed ID: 26742514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease.
    de la Monte SM; Vonsattel JP; Richardson EP
    J Neuropathol Exp Neurol; 1988 Sep; 47(5):516-25. PubMed ID: 2971785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy.
    Sawiak SJ; Wood NI; Morton AJ
    J Huntingtons Dis; 2016 Oct; 5(3):271-283. PubMed ID: 27662335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
    Kenney C; Powell S; Jankovic J
    Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Huntington's disease as caused by 34 CAG repeats.
    Andrich J; Arning L; Wieczorek S; Kraus PH; Gold R; Saft C
    Mov Disord; 2008 Apr; 23(6):879-81. PubMed ID: 18307262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlations between triplet repeat expansion and clinical features in Huntington's disease.
    Claes S; Van Zand K; Legius E; Dom R; Malfroid M; Baro F; Godderis J; Cassiman JJ
    Arch Neurol; 1995 Aug; 52(8):749-53. PubMed ID: 7639626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and genetic study of juvenile form of Huntington's disease].
    Zdzienicka E; Rakowicz M; Mierzewska H; Hoffman-Zacharska D; Jakubowska T; Poniatowska R; Sułek A; Waliniowska E; Zalewska U; Kulczycki J; Zaremba J
    Neurol Neurochir Pol; 2002; 36(2):245-58. PubMed ID: 12046502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study on Huntington's disease associated trinucleotide repeat within the Chinese population.
    Soong BW; Wang JT
    Proc Natl Sci Counc Repub China B; 1995 Jul; 19(3):137-42. PubMed ID: 7480359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.
    Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J
    Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited expansion of the (CAG)n repeat of the Huntington gene: a premutation (?).
    Legius E; Cuppens H; Dierick H; Van Zandt K; Dom R; Fryns JP; Evers-Kiebooms G; Decruyenaere M; Demyttenaere K; Marynen P
    Eur J Hum Genet; 1994; 2(1):44-50. PubMed ID: 8044653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adult-onset Huntington's disease that presented without chorea.
    Iwata A; Ishihara K; Tsuji S
    Intern Med; 2013; 52(18):2121-2. PubMed ID: 24042524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.
    Hoss AG; Labadorf A; Latourelle JC; Kartha VK; Hadzi TC; Gusella JF; MacDonald ME; Chen JF; Akbarian S; Weng Z; Vonsattel JP; Myers RH
    BMC Med Genomics; 2015 Mar; 8():10. PubMed ID: 25889241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.